Skip to main content
. 2020 May 11;61(5):8. doi: 10.1167/iovs.61.5.8

Table 2.

Summary of Quantitative OCTA Features for Different DR Severity Levels

Healthy Control n = 33 No-DR n = 51 Mild n = 41 Mod/Severe Proliferative
Outcomes Area Mean (± SD) Mean (± SD) Mean (± SD) n = 37 Mean (± SD) n = 30 Mean (± SD)
PD of SCC Parafovea 0.50 (0.02) 0.50 (0.02) 0.48 (0.03) 0.45 (0.04) 0.42 (0.04)
Temporal 0.46 (0.02)* 0.47 (0.03)* 0.45 (0.04)* 0.39 (0.05)* 0.33 (0.07)*
Nasal 0.45 (0.04)* 0.46 (0.03)* 0.46 (0.04)* 0.40 (0.05)* 0.35 (0.08)*
FD of SCC Parafovea 1.72 (0.01) 1.72 (0.01) 1.71 (0.01) 1.70 (0.01) 1.68 (0.02)
Temporal 1.70 (0.01)* 1.71 (0.01)* 1.70 (0.01)* 1.68 (0.02)* 1.65 (0.05)*
Nasal 1.71 (0.01)* 1.70 (0.01)* 1.70 (0.01)* 1.68 (0.02)* 1.66 (0.05)*
PD of DCC Parafovea 0.49 (0.02) 0.48 (0.03) 0.47 (0.02) 0.44 (0.04) 0.43 (0.05)
Temporal 0.50 (0.02) 0.48 (0.02) 0.48 (0.03) 0.41 (0.07) 0.39 (0.09)
Nasal 0.50 (0.03) 0.48 (0.03) 0.47 (0.03) 0.38 (0.08) 0.39 (0.08)

Outcomes grouped according to retinal topography of 3 × 3 mm scanning areas. For the outcomes of the SCC, the area directly nasal to the optic disc was excluded because it showed significantly higher values than the supero- and inferonasal areas. Values in bold letters are significantly different to outcomes of DR severity one stage lower. Values marked with * are significantly different to values measured in the parafovea. The P values were adjusted according to the Tukey multiple testing method.

Mod = moderate.